Complete Remission After Immunotherapy-Induced Abdominal Tuberculosis in a Patient With Advanced NSCLC Treated With Pembrolizumab: A Case Report - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement Access content directly
Journal Articles JTO Clinical and Research Reports Year : 2022

Complete Remission After Immunotherapy-Induced Abdominal Tuberculosis in a Patient With Advanced NSCLC Treated With Pembrolizumab: A Case Report

Dates and versions

hal-04521699 , version 1 (26-03-2024)

Identifiers

Cite

Mariona Riudavets, Benjamin Wyplosz, Maria Rosa Ghigna, Angela Botticella, Pamela Abdayem, et al.. Complete Remission After Immunotherapy-Induced Abdominal Tuberculosis in a Patient With Advanced NSCLC Treated With Pembrolizumab: A Case Report. JTO Clinical and Research Reports, 2022, 3 (5), pp.100319. ⟨10.1016/j.jtocrr.2022.100319⟩. ⟨hal-04521699⟩
3 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More